Ezetimibe for treating primary heterozygous-familial and non-familial hypercholesterolaemia

  • Technology appraisal guidance
  • TA385
  • Published: 

History

Guidance published

Expected publication

Final appraisal determination

Draft guidance

Invitation to participate

Final scope

NICE response to comments on the draft scope and provisional matrix

Provisional matrix (post referral)

Draft scope (post referral)